3SBio Inc. Files Annual Report on Form 20-F for Fiscal Year 2012

       3SBio Inc. Files Annual Report on Form 20-F for Fiscal Year 2012

PR Newswire

SHENYANG, China, May 1, 2013

SHENYANG, China, May 1, 2013 /PRNewswire/ --3SBio Inc. (NASDAQ: SSRX)
("3SBio" or "the Company"), a leading China-based biotechnology company
focused on researching, developing, manufacturing and marketing
biopharmaceutical products, today announced that it has filed the Company's
Annual Report on Form 20-F for the fiscal year ended December 31, 2012 with
the U.S. Security and Exchange Commission on April 30, 2013. The annual report
on Form 20-F, which contains its audited financial statements, can be accessed
on the SEC's website at http://www.sec.gov or on the Investor section of the
Company's website www.3sbio.com. Shareholders may also receive a hard copy of
the annual report free of charge upon request.

About 3SBio Inc.

3SBio is a leading, fully integrated, profitable biotechnology company focused
on researching, developing, manufacturing and marketing biopharmaceutical
products primarily in China. Its focus is on addressing large markets with
significant unmet medical needs in nephrology, oncology, supportive cancer
care, inflammation and infectious diseases. With headquarters and
GMP-certified manufacturing facilities in Shenyang, PRC, 3SBio employs over
800 people. Shares trade in the form of American Depositary Shares (ADSs) on
the NASDAQ stock market under the ticker symbol "SSRX". Please see
www.3SBio.com for more information.

Investor Contacts

Bo Tan
Chief Financial Officer
3SBio Inc.
Tel: + 86 24 2581-1820
ir@3SBio.com 

Tom Folinsbee
Director of Investor Relations
3SBio Inc.
Tel: + 852 8191-6991
ir@3SBio.com

SOURCE 3SBio Inc.

Website: http://www.3sbio.com
 
Press spacebar to pause and continue. Press esc to stop.